Clinical Trials in Houston

Showing 301-320 of 8,625 trials

F15 Recharge Free Axonics SNM System Clinical Study

NCT06186765

Multicenter, prospective, non randomized, single arm evaluation of patients with overactive bladder (OAB) and/or fecal incontinence (FI) employing the Axonics recharge free SNM System.

Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Fecal Incontinence (FI)

Axonics, Inc.144 participantsStarted Dec 2023

Waterford, Connecticut, United States • Bradenton, Florida, United States • Jacksonville, Florida, United States +13 more locations

RECRUITINGPHASE1< 1 mile

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

NCT06563375

To evaluate the safety and preliminary efficacy of NP-101 in patients with solid tumors.

Solid Tumor

M.D. Anderson Cancer Center35 participantsStarted Mar 2025

Houston, Texas, United States

RECRUITINGPHASE1< 1 mile

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

NCT06598800

This is a first-in-human (FIH), Phase 1a/1b, open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-T187 alone and in combination with other therapeutic agents in participants with advanced solid tumors.

Advanced Solid Tumor

BeiGene87 participantsStarted Oct 2024

Hackensack, New Jersey, United States • Houston, Texas, United States • Fairfax, Virginia, United States +23 more locations

F15 Recharge Free Axonics SNM System Clinical Study

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

Find Trials by Condition in Houston

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

A Study of Dotinurad Versus Allopurinol in Participants With Gout

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

Study of DONQ52 in Active Celiac Disease

Secukinumab Open Label Roll-over Extension Protocol

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform